A Study Investigating the Pharmacokinetics (PK) of a single dose administration of Cotadutide (MEDI0382)

Study identifier:D5670C00025

ClinicalTrials.gov identifier:NCT04091373

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase 1, Randomized, Open-label, Single Center, Three Period Cross-over Study to Evaluate the Pharmacokinetics of Single Dose Administration of Cotadutide in Healthy Subjects

Medical condition

Type 2 Diabetes Mellitus

Phase

Phase 1

Healthy volunteers

Yes

Study drug

MEDI0382

Sex

All

Actual Enrollment

36

Study type

Interventional

Age

18 Years - 60 Years

Date

Study Start Date: 27 Sept 2019
Primary Completion Date: 06 Mar 2020
Study Completion Date: 06 Mar 2020

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: -
Primary Purpose: Other

Verification:

Verified 01 Jan 2021 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria